Insulet Corp (PODD) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Insulet reported revenue of $2.71B, up 30.7% from $2.07B the year before. Net income was $247.1M (a 9.1% net margin), or $3.48 per diluted share. Gross margin was 71.6% and operating margin was 17.5%. Operating activities generated $569.3M of cash, leaving $377.7M of free cash flow. At fiscal year end, Insulet held $3.19B in total assets against $1.68B in total liabilities.
Open the full interactive Insulet financials → Quarterly statements, key ratios, valuation history and price charts.
Insulet Key Stats
| Share Price | $138.13 |
|---|---|
| Market Cap | $9.59B |
| P/E Ratio | 39.7 |
| Revenue YoY Growth | +30.7% |
| 52-Week Range | $130.47 – $346.36 |
| Shares Outstanding | 69.3 million (basic, 2026 Q2) |
Insulet Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $904.4M | $1.10B | $1.31B | $1.70B | $2.07B | $2.71B |
| Cost of Goods Sold | $322.1M | $346.7M | $499.7M | $537.2M | $625.9M | $768.2M |
| Gross Profit | $582.3M | $752.1M | $805.6M | $1.16B | $1.45B | $1.94B |
| Operating Income | $51.5M | $126.0M | $37.6M | $220.0M | $308.9M | $473.8M |
| Pre-Tax Income | $9.7M | $20.5M | $9.8M | $214.6M | $300.2M | $339.5M |
| Income Tax | $2.9M | $3.7M | $5.2M | $8.3M | -$118.1M | $92.4M |
| Net Income | $6.8M | $16.8M | $4.6M | $206.3M | $418.3M | $247.1M |
| Diluted EPS | $0.10 | $0.24 | $0.07 | $2.94 | $5.78 | $3.48 |
Insulet Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $706.3M | $783.7M | $761.7M | $801.7M |
| Net Income | $87.6M | $101.6M | $91.1M | $95.0M |
| Diluted EPS | $1.24 | $1.41 | $1.30 | $1.37 |
Insulet Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $907.2M | — | — | — | — | — |
| Current Assets | $1.25B | $1.33B | $1.31B | $1.58B | $1.89B | $1.91B |
| Total Assets | $1.87B | $2.05B | $2.25B | $2.59B | $3.09B | $3.19B |
| Current Liabilities | $207.8M | $228.8M | $364.7M | $451.2M | $528.4M | $680.1M |
| Total Long-Term Debt | $1.06B | $1.27B | $1.40B | $1.42B | $1.38B | $949.2M |
| Total Liabilities | $1.27B | $1.49B | $1.77B | $1.86B | $1.88B | $1.68B |
| Shareholders' Equity | $603.6M | $556.3M | $476.4M | $732.7M | $1.21B | $1.52B |
Insulet Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $84.0M | -$68.1M | $119.0M | $145.7M | $430.3M | $569.3M |
| Cash From Investing | $14.0M | -$82.7M | -$191.1M | -$119.4M | -$146.2M | -$222.7M |
| Cash From Financing | $605.5M | $40.7M | -$40.3M | -$13.6M | -$28.1M | -$595.3M |
| Free Cash Flow | -$45.0M | -$180.0M | -$3.9M | $70.1M | $305.4M | $377.7M |
Figures from Insulet's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Insulet financials page for every line item.
Insulet Company Profile
| Ticker | PODD |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Acton, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001145197 |
Frequently Asked Questions
What was Insulet's revenue in fiscal 2025?
Insulet (PODD) reported revenue of $2.71B for fiscal 2025.
What is Insulet's annual revenue history?
Insulet's annual revenue by fiscal year: 2020: $904.4M; 2021: $1.10B; 2022: $1.31B; 2023: $1.70B; 2024: $2.07B; 2025: $2.71B.
What was Insulet's net income in fiscal 2025?
Insulet reported net income of $247.1M for fiscal 2025.
What was Insulet's earnings per share (EPS) in fiscal 2025?
Insulet's diluted EPS was $3.48 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Insulet generate in fiscal 2025?
Insulet generated $377.7M of free cash flow in fiscal 2025.
What was Insulet's revenue last quarter?
In its most recent reported quarter (2026 Q2), Insulet reported revenue of $801.7M.
How much debt does Insulet have?
Insulet reported $949.2M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Insulet are outstanding?
Insulet reported a weighted average of 69.3 million basic shares outstanding in 2026 Q2.
What is Insulet's market cap?
Based on its latest closing price, Insulet (PODD) has a market capitalization of about $9.59B.
When does Insulet's fiscal year end?
Insulet's fiscal year end, as registered with the SEC, is December 31.
Where is Insulet headquartered?
Insulet lists its business address in Acton, Massachusetts in its SEC filings.